← Back to Search

Group 3: ECG+SpO2+RFM+NIRS for Premature Infants

N/A
Waitlist Available
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during resuscitation
Awards & highlights

Study Summary

This trial is designed to study if adding machines that measure how well a baby is breathing during resuscitation (RFM and cNIRS) increases how stressed healthcare providers feel, and makes it harder for them to focus on the task.

Eligible Conditions
  • Premature Infants

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Team Leader's NASA Task Load Index (NASA-TLX) Mental Demand
Secondary outcome measures
Composite team mental workload
Frequency of visual fixation to monitoring equipment Visual Access to each monitor display type (vital signs, RFM, NIRS)
Severe Bronchopulmonary Dysplasia
+7 more

Trial Design

3Treatment groups
Active Control
Group I: Group 3: ECG+SpO2+RFM+NIRSActive Control2 Interventions
Addition of cerebral NIRS and Respiratory Function Monitor to ECG and SpO2 during resuscitation.
Group II: Group 2: ECG+SpO2+RFMActive Control1 Intervention
Addition of Respiratory Function Monitor to ECG and SpO2 during resuscitation.
Group III: Group1: ECG+SpO2 onlyActive Control1 Intervention
Traditional ECG (heart rate) and SpO2 (pulse oximetry) monitoring for resuscitation only.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,087 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Apr 2025